Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1980-5-14
|
pubmed:abstractText |
The prothrombin time (PT) of a patient undergoing warfarin sodium anticoagulation became elevated when sulfisoxazole was given concurrently. The warfarin dose index is used to demonstrate that this PT prolongation was the result of a warfarin-sulfisoxazole interaction. The mechanism of this interaction may involve displacement of warfarin from serum albumin. Sulfisoxazole should be used cautiously, if at all, in patients taking warfarin.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0003-9926
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
140
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
546-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7362390-Aged,
pubmed-meshheading:7362390-Blood Coagulation,
pubmed-meshheading:7362390-Drug Synergism,
pubmed-meshheading:7362390-Female,
pubmed-meshheading:7362390-Humans,
pubmed-meshheading:7362390-Pulmonary Embolism,
pubmed-meshheading:7362390-Sulfisoxazole,
pubmed-meshheading:7362390-Urinary Tract Infections,
pubmed-meshheading:7362390-Warfarin
|
pubmed:year |
1980
|
pubmed:articleTitle |
Potentiation of warfarin anticoagulation by sulfisoxazole.
|
pubmed:publicationType |
Journal Article,
Case Reports
|